Erler JT - Search Results

1

Lysyl oxidase is essential for hypoxia-induced metastasis.

Erler JT, Bennewith KL, Nicolau M, Dornhöfer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ. Erler JT, et al. Nature. 2006 Apr 27;440(7088):1222-6. doi: 10.1038/nature04695. Nature. 2006. Retraction in: Nature. 2020 Mar;579(7799):456. doi: 10.1038/s41586-020-2112-4 PMID: 16642001 Retracted.

2

Lysyl oxidase mediates hypoxic control of metastasis.

Erler JT, Giaccia AJ. Erler JT, et al. Cancer Res. 2006 Nov 1;66(21):10238-41. doi: 10.1158/0008-5472.CAN-06-3197. Cancer Res. 2006. PMID: 17079439 Review.

3

Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.

Le QT, Kong C, Lavori PW, O'byrne K, Erler JT, Huang X, Chen Y, Cao H, Tibshirani R, Denko N, Giaccia AJ, Koong AC. Le QT, et al. Among authors: erler jt. Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):167-75. doi: 10.1016/j.ijrobp.2007.01.071. Int J Radiat Oncol Biol Phys. 2007. PMID: 17707270

4

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.

Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT, Giaccia AJ. Erler JT, et al. Cancer Cell. 2009 Jan 6;15(1):35-44. doi: 10.1016/j.ccr.2008.11.012. Cancer Cell. 2009. PMID: 19111879 Free PMC article.

5

The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth.

Bennewith KL, Huang X, Ham CM, Graves EE, Erler JT, Kambham N, Feazell J, Yang GP, Koong A, Giaccia AJ. Bennewith KL, et al. Among authors: erler jt. Cancer Res. 2009 Feb 1;69(3):775-84. doi: 10.1158/0008-5472.CAN-08-0987. Cancer Res. 2009. PMID: 19179545 Free PMC article.

6

Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.

Le QT, Harris J, Magliocco AM, Kong CS, Diaz R, Shin B, Cao H, Trotti A, Erler JT, Chung CH, Dicker A, Pajak TF, Giaccia AJ, Ang KK. Le QT, et al. Among authors: erler jt. J Clin Oncol. 2009 Sep 10;27(26):4281-6. doi: 10.1200/JCO.2008.20.6003. Epub 2009 Aug 10. J Clin Oncol. 2009. PMID: 19667273 Free PMC article.

7

Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours.

Granchi C, Funaioli T, Erler JT, Giaccia AJ, Macchia M, Minutolo F. Granchi C, et al. Among authors: erler jt. ChemMedChem. 2009 Oct;4(10):1590-4. doi: 10.1002/cmdc.200900247. ChemMedChem. 2009. PMID: 19685543 Free PMC article. No abstract available.

8

Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM. Levental KR, et al. Among authors: erler jt. Cell. 2009 Nov 25;139(5):891-906. doi: 10.1016/j.cell.2009.10.027. Cell. 2009. PMID: 19931152 Free PMC article.

9

Hypoxia in models of lung cancer: implications for targeted therapeutics.

Graves EE, Vilalta M, Cecic IK, Erler JT, Tran PT, Felsher D, Sayles L, Sweet-Cordero A, Le QT, Giaccia AJ. Graves EE, et al. Among authors: erler jt. Clin Cancer Res. 2010 Oct 1;16(19):4843-52. doi: 10.1158/1078-0432.CCR-10-1206. Epub 2010 Sep 21. Clin Cancer Res. 2010. PMID: 20858837 Free PMC article.

10

LOXL2-mediated matrix remodeling in metastasis and mammary gland involution.

Barker HE, Chang J, Cox TR, Lang G, Bird D, Nicolau M, Evans HR, Gartland A, Erler JT. Barker HE, et al. Among authors: erler jt. Cancer Res. 2011 Mar 1;71(5):1561-72. doi: 10.1158/0008-5472.CAN-10-2868. Epub 2011 Jan 13. Cancer Res. 2011. PMID: 21233336 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters